Synonyms: | |
Status: | Phase 2 |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
UNII: | 97C5T2UQ7J |
InChI Key | HVYWMOMLDIMFJA-DPAQBDIFSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C27H46O |
Molecular Weight | 386.66 |
AlogP | 7.39 |
Hydrogen Bond Acceptor | 1.0 |
Hydrogen Bond Donor | 1.0 |
Number of Rotational Bond | 5.0 |
Polar Surface Area | 20.23 |
Molecular species | NEUTRAL |
Aromatic Rings | 0.0 |
Heavy Atoms | 28.0 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Ion channel
Voltage-gated ion channel
Voltage-gated sodium channel
|
- | - | - | - | 3 | |
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 1
Nuclear hormone receptor subfamily 1 group F
Nuclear hormone receptor subfamily 1 group F member 3
|
20-418 | - | - | - | - | |
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 100 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Asperger Syndrome | 1 | D020817 | ClinicalTrials |
Autistic Disorder | 1 | D001321 | ClinicalTrials |
Head and Neck Neoplasms | 1 | D006258 | ClinicalTrials |
Smith-Lemli-Opitz Syndrome | 1 | D019082 | ClinicalTrials |
Porokeratosis | 1 | D017499 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 57-88-5 |
ChEBI | 16113 |
ChEMBL | CHEMBL112570 |
DrugBank | DB04540 |
EPA CompTox | DTXSID3022401 |
FDA SRS | 97C5T2UQ7J |
Human Metabolome Database | HMDB0000067 |
Guide to Pharmacology | 2718 |
KEGG | C00187 |
PDB | CLR |
PubChem | 5997 |
SureChEMBL | SCHEMBL2156 |
ZINC | ZINC000003875383 |